NPI: 1467552471 · FAIRFIELD, OH 45014 · General Acute Care Hospital · NPI assigned 09/22/2006
Authorized official RALSTON, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | RALSTON, KIMBERLY (VP REIMBURSEMENT) |
| NPI Enumeration Date | 09/22/2006 |
Other providers sharing the same authorized official: RALSTON, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 91,289 | $2.76M |
| 2019 | 70,724 | $2.47M |
| 2020 | 51,580 | $2.16M |
| 2021 | 49,087 | $2.12M |
| 2022 | 59,676 | $2.45M |
| 2023 | 248,439 | $7.71M |
| 2024 | 168,770 | $5.50M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 46,073 | 42,815 | $5.42M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 28,805 | 25,665 | $3.39M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17,273 | 14,596 | $2.20M |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,641 | 5,401 | $1.34M |
| 70450 | Computed tomography, head or brain; without contrast material | 6,247 | 5,334 | $1.30M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 23,595 | 6,453 | $1.17M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4,823 | 4,055 | $1.16M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,154 | 6,788 | $701K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,244 | 1,070 | $548K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 11,604 | 3,442 | $547K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 8,293 | 5,519 | $540K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,826 | 1,534 | $446K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 2,124 | 893 | $432K |
| G0378 | Hospital observation service, per hour | 4,702 | 1,792 | $319K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,891 | 1,893 | $310K |
| 80053 | Comprehensive metabolic panel | 42,359 | 36,854 | $301K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,671 | 1,624 | $298K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,005 | 1,863 | $274K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,716 | 1,434 | $248K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 11,014 | 4,774 | $245K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 615 | 500 | $227K |
| 95811 | 345 | 324 | $184K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 7,975 | 2,677 | $177K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1,974 | 1,937 | $174K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 887 | 754 | $173K |
| 64483 | 276 | 260 | $135K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 219 | 195 | $122K |
| 70496 | 591 | 484 | $120K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4,432 | 3,846 | $106K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 621 | 456 | $96K |
| 97161 | 2,694 | 2,274 | $94K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 720 | 619 | $90K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,412 | 680 | $87K |
| 76642 | 636 | 554 | $76K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,624 | 1,474 | $72K |
| 84484 | 19,228 | 13,593 | $70K | |
| 71046 | Radiologic examination, chest; 2 views | 11,054 | 10,140 | $69K |
| 80048 | Basic metabolic panel (calcium, ionized) | 10,606 | 8,110 | $63K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 598 | 519 | $56K |
| 93017 | 724 | 604 | $56K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 386 | 355 | $54K |
| 71250 | 743 | 650 | $52K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 53,185 | 44,606 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 24,678 | 21,035 | $47K |
| 97113 | 735 | 262 | $44K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2,243 | 1,980 | $43K |
| 80061 | Lipid panel | 2,244 | 2,034 | $42K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 256 | 237 | $39K |
| 76536 | 350 | 312 | $37K | |
| 47563 | 13 | 12 | $35K | |
| 94726 | 481 | 429 | $35K | |
| 97016 | 1,225 | 359 | $35K | |
| 83880 | 6,116 | 5,191 | $35K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 71 | 55 | $35K |
| 59025 | Fetal non-stress test | 212 | 147 | $34K |
| 86900 | 1,903 | 1,439 | $32K | |
| 71045 | Radiologic examination, chest; single view | 12,303 | 10,697 | $30K |
| 36415 | Collection of venous blood by venipuncture | 32,481 | 25,574 | $28K |
| 93975 | 219 | 177 | $27K | |
| 71271 | 164 | 154 | $24K | |
| 72100 | 755 | 671 | $24K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,148 | 1,031 | $23K |
| 97165 | 571 | 472 | $23K | |
| 94729 | 465 | 418 | $23K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 1,681 | 1,433 | $23K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,748 | 1,442 | $23K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 88 | 79 | $21K |
| 93971 | 305 | 277 | $21K | |
| 76770 | 125 | 117 | $21K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 307 | 198 | $19K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,155 | 1,846 | $19K |
| 97116 | 947 | 501 | $18K | |
| 97162 | 709 | 609 | $18K | |
| 72131 | 227 | 193 | $17K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 1,570 | 1,434 | $17K |
| 76830 | Ultrasound, transvaginal | 404 | 348 | $16K |
| 70486 | 349 | 302 | $15K | |
| 77065 | Tomosynthesis, mammo | 468 | 372 | $15K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 85 | 72 | $14K |
| 94060 | 165 | 150 | $14K | |
| 83605 | 4,202 | 2,992 | $14K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 80 | 63 | $14K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 64 | 52 | $13K |
| 80069 | 902 | 660 | $13K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,686 | 1,447 | $13K |
| 85027 | 2,698 | 2,034 | $13K | |
| 73562 | 589 | 524 | $12K | |
| 73030 | 899 | 767 | $12K | |
| 86850 | 1,440 | 1,044 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8,439 | 5,842 | $12K |
| 99152 | 1,915 | 1,665 | $12K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 62 | 56 | $12K |
| 77066 | Tomosynthesis, mammo | 357 | 329 | $11K |
| 64493 | 14 | 13 | $11K | |
| 84703 | 19,082 | 16,859 | $11K | |
| 97535 | Self-care/home management training, each 15 minutes | 691 | 428 | $10K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 455 | 356 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | 12,280 | 10,050 | $10K |
| 81001 | 21,387 | 18,910 | $10K | |
| 73630 | 900 | 780 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 18,014 | 15,608 | $9K |
| 12001 | 62 | 51 | $9K | |
| 90714 | 646 | 502 | $9K | |
| 95806 | 14 | 14 | $8K | |
| 82607 | 862 | 760 | $8K | |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | 434 | 189 | $8K |
| 88307 | 73 | 40 | $8K | |
| 73130 | 629 | 536 | $8K | |
| 82570 | 959 | 766 | $8K | |
| 83690 | 15,333 | 13,368 | $8K | |
| 74018 | 279 | 237 | $7K | |
| 73560 | 432 | 362 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 7,850 | 6,934 | $7K |
| 70491 | 28 | 28 | $6K | |
| 11045 | 27 | 13 | $6K | |
| 85610 | 6,129 | 4,338 | $6K | |
| 73502 | 381 | 348 | $6K | |
| 73610 | 699 | 620 | $6K | |
| 70498 | 596 | 490 | $6K | |
| 77080 | 105 | 83 | $6K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 659 | 600 | $6K |
| 84439 | 554 | 484 | $6K | |
| 83540 | 752 | 656 | $6K | |
| 87040 | 1,886 | 844 | $6K | |
| 80076 | 1,210 | 998 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 8,650 | 4,023 | $6K |
| 83550 | 710 | 623 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,159 | 1,756 | $5K |
| 82746 | 778 | 690 | $5K | |
| 83735 | 4,009 | 2,817 | $5K | |
| 72141 | 44 | 38 | $5K | |
| J8501 | Aprepitant, oral, 5 mg | 450 | 323 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 112 | 36 | $5K |
| 82728 | 415 | 361 | $5K | |
| 86901 | 1,894 | 1,438 | $4K | |
| 96376 | 1,957 | 979 | $4K | |
| 84702 | 1,534 | 1,206 | $4K | |
| 86140 | 682 | 539 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,686 | 1,449 | $4K |
| 82565 | 535 | 466 | $4K | |
| 81003 | 6,838 | 5,771 | $4K | |
| 73110 | 386 | 329 | $4K | |
| 96367 | 310 | 202 | $4K | |
| 86701 | 134 | 103 | $3K | |
| 72040 | 85 | 73 | $3K | |
| 87081 | 1,885 | 1,607 | $3K | |
| 82077 | 1,448 | 1,121 | $3K | |
| 82043 | 465 | 430 | $3K | |
| 83970 | 128 | 105 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,228 | 1,194 | $3K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 19 | 18 | $3K |
| C1769 | Guide wire | 761 | 528 | $3K |
| 99153 | Mod sedat endo service >5yrs | 271 | 213 | $3K |
| 84156 | 501 | 431 | $3K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 13 | 12 | $3K |
| 85379 | 1,856 | 1,571 | $2K | |
| 85730 | 1,621 | 1,321 | $2K | |
| 87390 | 125 | 102 | $2K | |
| 20560 | 93 | 26 | $2K | |
| J3490 | Unclassified drugs | 312 | 100 | $2K |
| 12011 | 12 | 12 | $2K | |
| 72110 | 29 | 29 | $2K | |
| 86702 | 125 | 102 | $2K | |
| 85652 | 722 | 575 | $2K | |
| 00731 | 1,257 | 1,063 | $2K | |
| 12002 | 13 | 13 | $2K | |
| 84425 | 125 | 119 | $1K | |
| 82550 | 619 | 496 | $1K | |
| 86803 | 77 | 62 | $1K | |
| 92610 | 46 | 42 | $1K | |
| 84100 | 581 | 380 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 673 | 514 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,203 | 1,897 | $1K |
| 87807 | 788 | 666 | $1K | |
| 97166 | 74 | 60 | $1K | |
| 64447 | 22 | 14 | $992.49 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2,332 | 1,462 | $943.65 |
| 84145 | 964 | 739 | $917.25 | |
| 76801 | 18 | 17 | $900.54 | |
| 80143 | 659 | 539 | $891.08 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 2,127 | 884 | $887.24 |
| 76870 | 14 | 12 | $838.57 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 255 | 238 | $832.74 |
| 87077 | 1,275 | 937 | $814.35 | |
| 82803 | 1,098 | 866 | $804.63 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 2,078 | 1,173 | $786.97 |
| 20561 | 38 | 24 | $778.49 | |
| 73140 | 72 | 45 | $761.98 | |
| 92526 | 18 | 14 | $743.96 | |
| 94150 | 18 | 16 | $731.67 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 106 | 68 | $692.78 |
| 84446 | 53 | 52 | $689.19 | |
| 87210 | 952 | 823 | $682.39 | |
| 87186 | 1,058 | 816 | $638.91 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,106 | 1,373 | $625.04 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 10,590 | 8,425 | $605.98 |
| 73590 | 99 | 87 | $605.91 | |
| 84590 | 41 | 41 | $545.16 | |
| 93325 | 15 | 14 | $459.76 | |
| 80179 | 637 | 529 | $456.89 | |
| 72050 | 15 | 14 | $425.25 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 617 | 457 | $405.04 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 11,475 | 9,643 | $381.67 |
| 73564 | 31 | 30 | $360.44 | |
| 88342 | 339 | 199 | $343.49 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,278 | 2,647 | $339.02 |
| 84550 | 58 | 43 | $294.92 | |
| J2704 | Injection, propofol, 10 mg | 7,043 | 3,883 | $292.62 |
| 80320 | 18 | 14 | $287.92 | |
| 73080 | 55 | 52 | $283.56 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 491 | 278 | $271.82 |
| 90715 | 16 | 14 | $269.88 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 79 | 64 | $257.70 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 10,534 | 7,934 | $246.53 |
| J0690 | Injection, cefazolin sodium, 500 mg | 2,214 | 1,337 | $169.85 |
| 94761 | 1,020 | 558 | $168.98 | |
| J2785 | Injection, regadenoson, 0.1 mg | 306 | 264 | $149.30 |
| 87070 | 182 | 105 | $146.51 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,583 | 1,062 | $142.43 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 4,892 | 3,470 | $140.50 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 324 | 259 | $129.94 |
| J1644 | Injection, heparin sodium, per 1000 units | 1,494 | 528 | $129.45 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 561 | 452 | $126.48 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2,045 | 1,472 | $125.19 |
| J3370 | Injection, vancomycin hcl, 500 mg | 419 | 222 | $122.38 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 285 | 170 | $121.17 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,225 | 2,964 | $110.40 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,426 | 894 | $109.47 |
| 73090 | 14 | 13 | $103.59 | |
| 87205 | 220 | 113 | $102.98 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,184 | 857 | $88.40 |
| J2060 | Injection, lorazepam, 2 mg | 713 | 468 | $76.90 |
| 84132 | 53 | 38 | $65.43 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 477 | 419 | $61.39 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 305 | 209 | $54.28 |
| J1790 | Injection, droperidol, up to 5 mg | 298 | 223 | $53.33 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 4,464 | 3,438 | $51.28 |
| 94760 | 1,354 | 1,092 | $51.00 | |
| 87088 | 123 | 93 | $50.32 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 61 | 36 | $42.57 |
| 82010 | 125 | 97 | $39.24 | |
| 94664 | 82 | 70 | $30.52 | |
| 82140 | 32 | 26 | $29.13 | |
| J1940 | Injection, furosemide, up to 20 mg | 163 | 83 | $24.79 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 180 | 95 | $24.12 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 888 | 702 | $20.26 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 979 | 655 | $16.69 |
| 85018 | 30 | 12 | $16.43 | |
| J7050 | Infusion, normal saline solution, 250 cc | 229 | 141 | $16.38 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 165 | 144 | $13.36 |
| 82962 | 109 | 99 | $9.28 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 15 | 13 | $9.02 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 151 | 101 | $7.80 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 77 | 52 | $6.96 |
| J1171 | Injection, hydromorphone, 0.1 mg | 133 | 61 | $5.49 |
| J3411 | Injection, thiamine hcl, 100 mg | 35 | 27 | $4.56 |
| J1630 | Injection, haloperidol, up to 5 mg | 149 | 107 | $4.12 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 154 | 45 | $2.36 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 329 | 285 | $0.51 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 100 | 62 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 73 | 69 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 82 | 71 | $0.00 |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 127 | 102 | $0.00 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | 41 | 25 | $0.00 |
| 88304 | 209 | 145 | $0.00 | |
| 64494 | 14 | 13 | $0.00 | |
| C1889 | Implantable/insertable device, not otherwise classified | 28 | 26 | $0.00 |
| 86308 | 31 | 24 | $0.00 | |
| 82150 | 34 | 32 | $0.00 | |
| 01480 | 39 | 28 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 16 | 15 | $0.00 |
| 00813 | 16 | 14 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 24 | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 55 | 50 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 15 | 12 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 13 | 12 | $0.00 |
| 00790 | 18 | 13 | $0.00 | |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 25 | 24 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 244 | 211 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 150 | 132 | $0.00 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 73 | 51 | $0.00 |
| 00840 | 52 | 24 | $0.00 | |
| H1003 | Prenatal care, at-risk enhanced service; education | 30 | 27 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 36 | 24 | $0.00 |
| J2720 | Injection, protamine sulfate, per 10 mg | 16 | 12 | $0.00 |
| 85014 | 33 | 12 | $0.00 | |
| J1953 | Injection, levetiracetam, 10 mg | 18 | 12 | $0.00 |
| 00812 | 89 | 61 | $0.00 | |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 13 | 12 | $0.00 |
| 85347 | 25 | 13 | $0.00 | |
| J1956 | Injection, levofloxacin, 250 mg | 57 | 40 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 17 | 14 | $0.00 |
| 74300 | 13 | 12 | $0.00 | |
| C1776 | Joint device (implantable) | 14 | 14 | $0.00 |